Quantification of subcellular glycogen in resting human muscle: granule size, number, and location. J Appl Physiol 93: 1598-1607, 2002. First published July 12, 2002 10.1152/ japplphysiol.00585.2001.-A few qualitative investigations suggested that location of muscle glycogen (G) granules in specific sites may be associated with distinct metabolic roles. Similarly, it has been suggested that the acid-soluble and -insoluble G fractions (macro-and proglycogen, respectively) are different metabolic pools and also could exist as separate entities. We employed a transmission electron microscopic technique to quantify subcellular G particle size, number, and location in human vastus lateralis biopsies of 11 resting men. The intra-and interobserver variability for the various measures was generally Ͻ4%. Granule size and number were quantified in subcellular compartments (subsarcolemmal, intra-and intermyofibrillar). Subcellular location was critical: G was more densely concentrated in the subsarcolemmal than in the myofibrillar space, whereas the single-particle volume was greater in the latter. Single-particle diameter ranged from 10 to 44 m and followed a continuous, normal distribution. This implies that proglycogen is not a distinct entity, but rather that pro-and macroglycogen are divisions of smaller and larger molecules. These results demonstrate a compartmentalized pattern of subcellular G deposition in human skeletal muscle for both the size and density of granules.
SINCE THE DISCOVERY OF GLYCOGEN by Claude Bernard, numerous investigators have addressed many aspects of its metabolism. Although muscle glycogen concentration has been routinely quantified biochemically, the subcellular organization of glycogen particles has been studied much less frequently and only with qualitative, descriptive transmission electron microscopy (TEM) methods. Wanson and Drochmans (31) performed the first comprehensive description of rabbit skeletal muscle glycogen in its particulate ␤-form. Drochmans (5) had previously examined negatively stained liver glycogen by using TEM and described three glycogen structures in liver: ␣-, ␤-, and ␥-particles. The ␣-particles were the typical liver rosettes, and the ␤-particles were the 20-to 30-m spheroid units forming the ␣-rosettes. The ␥-particles were identified as 3-m subunits of both ␣-and ␤-structures. The single ␤-particles described in muscles by Wanson and Drochmans (31) corresponded in size and shape to the ␤-subunits that constituted the ␣-rosettes in liver.
Scott and Still (28) proposed that particulate glycogen was not a molecule in the traditional static sense but rather a dynamic organelle. In 1970, Meyer et al. (21) were among the first to suggest that glycogen was complexed with proteins and represented a structural and functional unit of the muscle cells. Using TEM, they estimated the diameter of this glycogen particle to be 20-30 m. This value was in agreement with the average diameter (27 m) of ␤-glycogen particles previously described by Wanson and Drochmans (31) in intact muscles. It is now known that the granule is physically associated with a number of proteins, including glycogenin, glycogen synthase, glycogen phosphorylase, phosphorylase kinase, and phosphatase as well as scaffolding proteins [reviewed by Roach et al. (24) ]. This raises the distinct possibility that granules can be regulated regionally or even individually.
The term ␤-particle has been applied to this proteinglycogen complex and has been consistently described as a 20-to 30-m particle (26) . Several investigators have found the ␤-particles to be located mainly in the subsarcolemmal and intermyofibrillar space, in close proximity to the sarcoplasmic reticulum (SR) (9, 10, 26, 27, 29) . Rybicka (26) reviewed the area and clearly supported the concept that the structures commonly interpreted as particles of glycogen actually represent dynamic organelles (glycosomes), which act as independent metabolic units with specialized functions. A heterogeneous distribution of glycosomes could result in metabolic compartments with distinct characteris-tics and functions. For example, biochemical and morphological evidence has demonstrated the association of some glycosomes with the SR in both cardiac and skeletal muscles (12, 21, 23, 31, 32) . This subcellular location may represent a metabolic compartment dedicated to SR function.
Ekblom and co-workers (9, 10, 29) have provided most of our understanding of the compartmental distribution of skeletal muscle glycogen in humans. They used TEM to describe qualitatively the distribution of skeletal muscle glycogen in different subcellular locations, different muscle fiber types, and under different exercise conditions. They described glycogen as being stored in five topographically different locations (10) . They also reported that exercise of different intensities metabolized glycogen from specific subcellular locations and muscle fiber types and proposed a selective pattern of subcellular glycogen metabolism, depending on the exercise characteristics (9) . Furthermore, they described two separate and distinct populations of glycogen particles with diameters of 22 and 56 m. They speculated that these populations might represent the acid-soluble and -insoluble forms of glycogen previously described by Jansson (16) [now referred to as macro-and proglycogen, respectively (1, 2, 26) ]. Although the results of these early studies are interesting, the methodological approach used in estimating muscle glycogen concentration lacked the objectivity and detailed information of quantitative procedures. For example, their selection of fibers and subcellular locations was not systematic, and the sample sizes were restricted owing to the labor-intensive nature of TEM work and the lack of advanced computerized processes to assist in data collection and analysis.
The purposes of the present study were to 1) develop and validate a TEM method to quantify the subcellular distribution of muscle glycogen to facilitate an objective evaluation of glycogen granules and 2) apply this TEM technique to resting human muscle biopsy samples to quantify the distribution of glycogen in different subcellular locations. We hypothesized that 1) the technique would provide data showing statistical differences in glycogen granule density in various subcellular locations and 2) the distribution of granule diameter would be bimodal, in accordance with pools of pro-and macroglycogen.
METHODS

Subjects
The study was approved by the University of Guelph's Human Ethics Committee and conformed to the standards set by the Declaration of Helsinki. Eleven male subjects were informed in writing about the nature of the study, volunteered to participate, and signed a consent form. Mean (ϮSE) a ge, height, weight, and maximal oxygen consumption (V O2max) of the subjects were 25 Ϯ 1 yr, 184 Ϯ 2 cm, 86 Ϯ 2 kg, and 53 Ϯ 2 ml⅐ kg Ϫ1 ⅐ min Ϫ1 , respectively.
Procedures
Resting muscle biopsies were obtained from the vastus lateralis of the subjects by use of the percutaneous needle biopsy technique (15) . Each muscle sample was divided in two portions for biochemical and TEM analyses. Two independent investigators carried out the biochemical and TEM analyses.
Biochemical Analysis
A piece of each muscle biopsy was immediately frozen in liquid N 2 and subsequently stored at Ϫ80°C until it was freeze dried and dissected free of visible blood, connective tissue, and other nonmuscle elements. A 1.5-to 3.5-mg portion of freeze-dried muscle was extracted in 1.5 mM PCA and analyzed for pro-and macroglycogen (1) . Enzymatic measurement of glucosyl units (3) was then performed and reported as millimoles of glucosyl units per kilogram of dry muscle weight.
TEM Analysis
The remaining fresh muscle tissue was immediately fixed in 2.0% glutaraldehyde in 0.1% sodium cacodylate buffer. The samples were then postfixed in a solution of 1% osmium tetroxide and 1.5% potassium ferricyanide in 0.1 M sodium cacodylate. The combination of osmium tetroxide with potassium ferricyanide was used for enhanced contrast-staining of intramuscular glycogen as previously described (14) . The samples were then dehydrated in graded ethanol and subsequently infiltrated with graded mixtures of propylene oxide and Spurr's resin. Thin sections (ϳ70 m) were cut, and, for each sample, some sections were stained with uranyl acetate and lead citrate. After careful evaluation, it was concluded that the uranyl acetate and lead citrate staining were detrimental to glycogen analysis, and unstained sections were used for analysis. The nonspecific nature of the chemical staining induced by uranyl acetate and lead citrate renders essentially all cellular components considerably electron dense and thus reduces the contrast between glycogen particles and other cellular structures. The sections were examined and photographed in a JEOL 1200 EX electron microscope. For each session of electron microscopy, a standard calibration grid (cross-grating replica from SPI Supplies, West Chester, PA; 2160 grid lines/mm) was used to calculate the exact magnification.
A total of five to six muscle fibers were photographed from each muscle sample (i.e., each subject). For each of the fibers per muscle biopsy, a total of 11 images was obtained at ϫ20,000 magnification for glycogen distribution analysis. Figure 1 illustrates the protocol used for the selection of the 11 systematic sampling regions (images) within each fiber.
Our selection of different locations for the images (subsarcolemmal, superficial, and deep myofibrillar) was based on previous descriptions of the subcellular distribution of glycogen (9, 10, 27) . For a given fiber (Fig. 1) , images S1 to S5 comprised portions of the subsarcolemmal space: S1, one pole of a nucleus; S2, between the sarcolemma and a nucleus; S3, between a nucleus and the myofibrils; S4, sarcolemma adjacent to a cluster of mitochondria; and S5, sarcolemma lacking mitochondria. These sites were selected to gain representation of glycogen particles with respect to their association with the two main subsarcolemmal organelles, the nuclei and mitochondria. Images M1 to M6 were used to evaluate the myofibrillar space: M1, M3, and M5 represent myofibrils located immediately adjacent to the subsarcolemmal space ("superficial" myofibrillar space); M2, M4, and M6 were for analysis of myofibrils located toward the center of the muscle fiber diameter ("deep" myofibrillar space). Thus 55-66 images (ϫ20,000 magnification) were digitized and analyzed for each of the 11 subjects/biopsies.
A preliminary analysis was performed to determine the minimal number of images necessary to represent the myofibrillar space of one whole fiber. This analysis examined the change in the coefficient of variation (standard deviation/ mean ϫ 100) obtained for the dependent variables (discussed in TEM analysis: dependent variables), as more images were included in the analysis (33) . The coefficient of variation for the dependent variables decreased as the sampling increased from one to six images. There was no further decrease in the coefficient of variation with the addition of 7-10 data sets. On this basis, six myofibrillar samples were analyzed.
Digitizing
The images were digitized with the use of a cooled chargecoupled device camera and an Epi-illumination darkroom system (UVP, Upland, California). Each negative was digitized as two equal, half images to facilitate the analysis. A total of 22 images (11 negatives each divided into 2 images) was therefore used to represent each muscle fiber.
Analysis of Subcellular Glycogen Distribution
The analysis was conducted in three parts: 1) single-particle evaluation, 2) total glycogen, and 3) intra-and intermyofibrillar glycogen with the use of image analysis software (Image Pro Plus, ver. 4.0). The calculations are described in detail in a later section, but the following is a brief overview of each part of the analysis.
The single-particle analysis consisted of isolating the particles that were not clustered, determining the average single-particle diameter, and calculating the volume of a single particle. (There were no differences between the diameters of nonclustered and clustered particles.) These single-particle parameters were then compared between subcellular locations (subsarcolemmal space, superficial myofibrils, and deep myofibrils).
The total glycogen analysis consisted of determining both the total area of the image consisting of glycogen (glycogen area), as well as the number of glycogen particles that constituted this area (number of glycogen particles). The area was then converted to a volume (described below). Both the glycogen and the number of glycogen particles were compared between subcellular locations.
Finally, for both the deep and superficial myofibrillar images, the intra-and intermyofibrillar glycogen analysis consisted of dividing the amount of glycogen of each image into its respective intra-and intermyofibrillar region (Fig. 2) . The sum of these data was the myofibrillar glycogen for that image.
Reliability Testing
Because the present technique is novel as a process to quantify the subcellular distribution of muscle glycogen, an extensive evaluation of its reliability and validity was essential. To test the reliability of the method, both intra-and interobserver reliability were evaluated. The former involved the main investigator performing analysis of two subjects (i.e., images of 10 different fibers from 2 different biopsies) twice, at least 2 wk apart. For the latter, an independent investigator performed the analysis of three subjects (i.e., images of 15 different fibers from 3 different biopsies), which were also analyzed by the main investigator.
Our protocol to quantify the single-particle parameters did not differentiate between the intra-and intermyofibrillar particles. Therefore, before starting our single-particle analysis, it was necessary to ensure that the diameter of the single particles did not differ between these locations. Standard photographs and calibration grids were taken from three different samples [a subject with low muscle glycogen, a subject with high muscle glycogen, and a McArdle's disease (GSD V) patient with high muscle glycogen] at a magnification of ϫ40,000. An independent, blinded investigator manually outlined and traced individual glycogen particles in each of the intra-and intermyofibrillar spaces of different images from these samples. The MOP Videoplan program (Kontron, Germany) was precisely calibrated and used in this "manual" determination of the diameter of individual glycogen particles. A direct comparison was then performed between the intra-and intermyofibrillar particle diameters. Because the majority of the intermyofibrillar granules are arranged in clusters and the majority of the intramyofibrillar granules are isolated from each other (Fig. 2) , this analysis also allowed elimination of the possibility of a difference between the size of particles arranged in clusters compared with those that were isolated.
Calculations
Biochemical analysis. Total glycogen concentration was calculated as the sum of pro-and macroglycogen (1) . The percentage of total glycogen in the form of proglycogen (%PG) was determined by dividing the concentration of proglycogen by the total glycogen concentration and multiplying by 100 (%PG ϭ proglycogen/total glycogen ϫ 100).
TEM analysis: dependent variables. For each muscle fiber analyzed with TEM, the following dependent variables were obtained: 1) mean single-particle diameter (m) for deep myofibrillar space ( Ideally, data for the total fiber would be determined for each parameter, but this could only be calculated for the single-particle parameters (diameter and volume). The inability to obtain such a value for the number of glycogen particles and glycogen volume parameters, which are both expressed per m 3 of muscle tissue, was due to not knowing the relative proportion of muscle fiber as myofibrillar and subsarcolemmal spaces. Hence, each fraction was expressed separately for most parameters, and total myofibrillar value alone was used as a representation of the fiber. The average for all of the fibers analyzed in each biopsy was used to represent the biopsy.
The single-particle diameter was obtained by direct measurement of the granules on the digitized images. The mean single-particle volume was calculated, with the assumption that the glycogen granules are spheres, as follows: singleparticle volume ϭ 4r 3 /3, where is pi (3.141593) and r 3 is (diameter/2) 3 . Total glycogen area was divided by the mean single-particle area (both values obtained by direct measurement from the digitized images) and then by 0.070 m (thickness of a thin section) to obtain the number of glycogen particles per m 3 of muscle tissue. Glycogen volume was calculated by multiplying the number of glycogen particles (per m 3 ) by the mean single-particle volume (m 3 ) to obtain the glycogen volume (in m 3 /m 3 ) of muscle tissue (34) . The relative proportion of the myofibrillar glycogen located in the intramyofibrillar region was calculated and compared between subcellular locations (deep and superficial myofibrils). A ratio of the subsarcolemmal to total myofibrillar glycogen volume was calculated as was the percent of total myofibrillar glycogen volume that was in the intramyofibrillar space. Figure 3 illustrates a summary of the experimental design in which between 605 and 726 images were analyzed.
Intra-and interobserver reliability. Intra-and interobserver reliability were evaluated by using these calculations for each dependent variable: 1) the difference, 2) the %differ-ence, 3) the absolute difference, 4) the %absolute difference, 5) the squared root of the mean difference squared (RMS), 6) the %RMS, 7) the coefficient of correlation, and 8) t-test comparing the two respective groups of data. The following is a summary of the formula used to calculate the above mentioned criteria Fig. 2 . Distinction between intra-(Intra) and intermyofibrillar (Inter) glycogen. Photograph of a human muscle fiber (ϫ15,000 magnification) illustrating the difference between intra-and intermyofibrillar glycogen. Z, Z line; M, M line.
where X and Y represent the two analyses being compared [either two independent investigators (interobserver reliability) or two distinct analyses of the same investigator (intraobserver reliability)]; X i and Yi represent the dependent variable values for one single image, n is the number of images, and XAVG and YAVG represent the average values across all images within an analysis.
Statistics
Descriptive statistics were performed by using Microsoft Excel 1997. Inferential statistics were performed by using the SAS system (release 6.12). t-Tests were used to compare intra-and interobserver reliability. The multivariate repeated-measures design was assessed by using a mixed linear model with "subject" as the random effect and "subcellular locations and myofibrillar regions" as fixed effects. When these analyses revealed significant main effects or interactions, a Tukey's post hoc test was used to locate the pair-wise differences. Significance was considered to be P Ͻ 0.05. Data are presented as means Ϯ SE.
RESULTS
Biochemical Data
Subjects had an average total muscle glycogen concentration of 380 Ϯ 41 mmol/kg dm, and 74 Ϯ 2% was in the proglycogen form. Table 1 presents the results of the intra-and interobserver reliability testing for different variables. Our TEM technique of glycogen analysis is reliable and repeatable for a given examiner. The average percent difference between the two analyses was Ͻ2% for all the variables measured. In addition, the percentage of the RMS, a very conservative indicator of reliability, was Ͻ11% for each of the variables. Furthermore, a strong correlation, as indicated by r 2 , was significant for all the variables (P values not shown), and there were no significant differences between results of the two independent analyses performed by the main investigator.
Reliability Testing
Our TEM technique for glycogen analysis was reliable and repeatable between two independent investigators. The average percent difference between the results was Ͻ4% for all the variables measured.
Reliability was also evaluated by direct comparison between the intra-and intermyofibrillar single-particle diameters that were determined manually. The results for 3 different samples and more than 800 single particles revealed no difference between the diameter of the intra-and intermyofibrillar particles. In fact, the average diameter difference between intra-and intermyofibrillar particles was found to be of Ͻ0.5 m (P ϭ 0.25). Thus the data from the intra-and intermyofibrillar space were combined during the single-particle analyses. These results also suggest that the dimensions of granules are not different if they are in clusters. Fig. 3 . Summary of the experimental design. Each sample represented one subject (n ϭ 11 subjects) from which 5-6 fibers were analyzed. From each fiber, images were captured from different subcellular locations (subsarcolemmal, deep myofibrillar, and superficial myofibrillar). Myofibrillar images were further subdivided into myofibrillar regions (intra and inter). Dependent variables include single-particle diameter and volume, glycogen volume, number of glycogen particles, and intramyofibrillar, intermyofibrillar, and subsarcolemmal total myofibrillar glycogen volumes. Intra/myofib, relative proportion of myofibrillar glycogen volume located in the intramyofibrillar region; Inter/myofib, relative proportion of myofibrillar glycogen volume located in the intermyofibrillar region; Subsarcolemmal/Tmyofib, ratio of subsarcolemmal to total myofibrillar glycogen volume. No. of images, number of images that were analyzed by each of the investigators (interobserver reliability) or by the same investigator at two different points in time (intraobserver reliability) for that particular variable; 1st and 2nd means, individual means to be compared; ⌬, difference between the 1st and 2nd mean; %⌬, percentage of difference between 1st and 2nd mean; Absolute ⌬, absolute difference between the 1st and 2nd mean; %Absolute ⌬, percentage of absolute difference between 1st and 2nd mean; RMS, squared root of the mean difference squared; %RMS, percentage of the RMS; r 2 , coefficient of correlation between the two sets of images to be compared; t-test, P value of the t-test comparing the two sets of images. For a detailed explanation of the calculation, see METHODS. Figure 4 summarizes the results for single-particle analysis. There was a main effect of subcellular location (P Ͻ 0.0001). In addition, the average particle volume increased with depth in the fiber (Fig. 4) . Post hoc analysis revealed that the subsarcolemmal particle volume (7,376 Ϯ 48 m 3 ) was smaller than the superficial (8,462 Ϯ 55 m 3 ) and deep (8,802 Ϯ 57 m 3 ) myofibrillar particle volumes (both P Ͻ 0.0001). Figure 5 illustrates the distribution frequency for the single-particle diameter for all fibers of the 11 subjects (n Ͼ 55,000 particles). Particle size appears to be normally distributed and ranges from 10 to 44 m, with an average size of ϳ25 m. Clearly there is no indication of two distinct groups of granule sizes.
INTRAMUSCULAR GLYCOGEN GRANULE MORPHOLOGY
Dependent Variables
A main effect of subcellular location was present for both glycogen volume (P Ͻ 0.0001) and number of glycogen particles (P Ͻ 0.0001). Figure 6 illustrates the glycogen volume in each of the subcellular locations.
Although granule size was smaller in the subsarcolemmal space (Fig. 4) , the glycogen volume (m 3 of glycogen per m 3 of muscle tissue) was 59 and 74% greater in the subsarcolemmal space (0.037 Ϯ 0.001) than in the deep (0.023 Ϯ 0.002) and superficial (0.021 Ϯ 0.001) myofibrils, respectively (both P Ͻ 0.001). Although glycogen volume was 10% greater in the deep compared with the superficial myofibrils, consistent with single-particle volume results (Fig. 4) , these differences did not reach statistical significance (P ϭ 0.32). The number of glycogen particles (as expressed in number per m 3 of muscle tissue) followed the same pattern as the glycogen volume and was significantly greater in the subsarcolemmal space (5,152 Ϯ 332) than in the deep (2,741 Ϯ 146) and superficial (2,770 Ϯ 190) myofibrils (both P Ͻ 0.0001).
As expected, the intermyofibrillar region contained significantly more glycogen than the intramyofibrillar region. The former represented 87.8 Ϯ 1.1% of the myofibrillar glycogen. This was observed for both the glycogen volume (P Ͻ 0.0001) and the number of glycogen particles (P Ͻ 0.0001), with the individual particle diameter not being different between regions (see above).
DISCUSSION
The main goals of the present study were to 1) develop and validate a TEM method for quantifying the subcellular distribution of muscle glycogen and 2) quantify the distribution of human skeletal muscle glycogen in different subcellular compartments. We hypothesized that the TEM technique would provide data that could be quantified to demonstrate objectively that glycogen granule distribution is heterogeneous within the cell and that granule size is bimodal. We have established a valid and reliable TEM technique to quantify the subcellular distribution of muscle glycogen. The major findings using this new method were 1) the glycogen distribution in human skeletal muscle is compartmentalized and heterogeneous, with the glycogen particles being more concentrated in the subsarcolemmal space than in the myofibrillar space; 2) single-particle diameter followed a continuous, normal distribution pattern; and 3) single-particle volume is greater in the myofibrillar space compared with that in the subsarcolemmal space.
Method Validity and Reliability
The TEM technique for quantifying intramuscular glycogen distribution is reliable both within and between investigators. The coefficients of variation for all variables were Ͻ2% for intraobserver reliability and Ͻ3% for interobserver reliability. This level of variation is less than the 5-10% that has been reported (1, 7) for repeated analysis using standard biochemical methods for measuring muscle glycogen. Essen and Henriksson (8) reported the coefficient of variation for biochemically determined glycogen values for two parts of the same fiber to be 9%. In addition, on examination of similar fibers from serial sections of the same muscle, White and Snow (33) found the coefficient of variation for a histochemical technique (periodic acid Schiff staining) to be 8%.
Our method did not allow for a direct determination of total cellular glycogen as it was not possible to assess the volume relationship between the subsarcolemmal space, which has dense glycogen stores, and the total cell volume. It was not possible to measure individual muscle fiber circumference and volume, which is essential in calculating the relative contribution of the subsarcolemmal space to the total fiber volume. Because the diameter of individual muscle fibers is known to range from 10 to 100 m (18), the error introduced by an average value would be tremendous. Eisenberg (6) reported that the subsarcolemnal space is ϳ1 m wide. Thus, if one assumes that the fiber is round in cross section and that the diameter is 10, 50, or 100 m, the proportion of the intracellular space that would be myofibrillar would be 64, 92, or 96%, respectively. Thus it is probable that myofibrillar glyogen represents the vast majority of carbohydrate stores.
The goal of this study was not to develop another method for measuring intramuscular glycogen. Our technique is extremely time consuming compared with traditional biochemical methods, but it provides the ability to quantitatively evaluate glycogen in subcellular locations, as well as the particle size and number.
In addition, a number of assumptions were necessary to convert glycogen area into glycogen volume. These assumptions included that 1) the glycogen particles are spheres, 2) the section thickness is 70 m, and 3) the sections for TEM have a maximal thickness equal to the average particle diameter. Thus we assumed that no particles are located on top of each other.
The first two assumptions are valid; glycogen particles have been described consistently as regular spheroid organelles (12, 25, 26) . The section thickness (70 m) was precise within Ϯ10 m. With the section thickness of ϳ70 m and the average particle diameter of ϳ25 m, it is possible that, especially within the clusters, one to three glycogen particles could be located on top of each other and escape detection. The two-dimensional TEM images could not detect this juxtaposition. As detailed in METHODS, we obtained glycogen volume by multiplying the number of particles in a given image by the averaged single glycogen particle volume for that image. By doing so, we limited the third dimension (thickness) to the diameter one particle. We initially tried to evaluate the optical density of the glycogen particles. We compared the density of clusters to that of a single glycogen particle by assuming that clusters would be denser due to the effect of overlapping particles. However, a single isolated glycogen particle already displayed the maximal density. Given this limitation, we elected for the conservative protocol of restricting the third dimension (thickness) to the maximal particle diameter for each particular image.
The present method is the first objective, quantitative technique that has been applied to glycogen distribution in human skeletal muscle. We have demonstrated that the technique is valid and reliable. However, it could be improved in several ways. As discussed above, granule overlapping is a limitation. In addition, when one is examining a three-dimensional structure with varying diameters, there is not a uniform probability that all particles will be sectioned and observed (13) . To address this, two consecutive serial samples could have been taken. Finally, the fibers should have been fixed at resting length because shortening may have resulted in some spacial disturbance and overlap of granules.
Subcellular Locations
We found muscle glycogen to be heterogeneously distributed within the cell in a manner similar to what has been described qualitatively previously (9, 10, 27, 29) . Schmalbruch and Kamieniecka (27) reported glycogen granules to be either closely packed in strands marking the boundaries of the myofibrils in the I-band region or to be located in rows or as single granules within the myofibrils (see Fig. 2 ). Sjostrom et al. (29) extended these observations by reporting a third subcellular site of glycogen storage, the subsarcolemmal space. They characterized the intramuscular distribution of glycogen of their control subjects (i.e., resting) as 1) large subsarcolemmal accumulations, 2) large accumulations between the myofibrils (especially at I-band in close proximity to the mitochondria and SR), and 3) relatively smaller intramyofibrillar accumulations. They also reported that the intramyofibrillar glycogen particles were oriented as if they occupied a space previously filled with a thin or thick myofilament. In addition, Friden and colleagues (10) further emphasized an I-band-based location of glycogen, both for intra-and intermyofibrillar glycogen, and noted that the intramyofibrillar glycogen granules were INTRAMUSCULAR GLYCOGEN GRANULE MORPHOLOGY found both in horizontal rows beginning at the lateral border of the I band and extending toward the M line as well as longitudinal rows of single particles bordering the Z line. These observations were apparent in the present study (see Fig. 2 ).
These earlier experiments were insightful, but the methodological approach used in estimating muscle glycogen concentration was strictly qualitative. Because of the labor-intensive nature of TEM methods and the lack of advanced computerized processes to assist in data collection, these experiments' sample sizes were small, and sampling was not performed systematically. For example, in the investigations of human skeletal muscle (9, 10, 29) , the resting controls were four or five subjects, and in one case (10) there were only three subjects who exercised. Furthermore, the number of fibers sampled was rarely stated nor was there a detailed description of how subcellular sampling sites were determined.
In the present study, we provide the first quantitative analysis of subcellular glycogen location. We confirmed the presence of and quantified the characteristics of three morphologically distinct compartments in human skeletal muscle: subsarcolemmal, intramyofibrillar, and intermyofibrillar spaces. We found that the intermyofibrillar space is the largest glycogen compartment, although the subsarcolemmal space is more densely packed with glycogen granules, having almost twice the granule number per unit area than the myofibrillar space (Fig. 6) . Our results also confirm that the particles located between the myofilaments (intramyofibrillar region) were either isolated from each other or aligned in strands but never in clusters.
These anatomical compartments probably have metabolic significance. Friden and colleagues (9) compared the pattern of glycogen depletion during a marathon to that during an intense, anaerobic, sprint exercise. They found the subsarcolemmal glycogen fraction was not depleted at the end of a marathon, whereas the other locations were "empty." In contrast, in fibers of the three (10) and six (9) subjects who performed sprints, there was a marked depletion of subsarcolemmal pools, whereas the "perimitochondrial" locations remained intact at fatigue. They concluded that, depending on the type of exercise, differential sequential glycogen utilization patterns can be observed, and suggested a compartmentalized metabolism of glycogen. The present technique will facilitate evaluation of their hypothesis that the three subcellular glycogen storage sites represent distinct metabolic compartments.
Our findings represent the first evidence of a graded increase in single glycogen particle size from the sarcolemma to the center of the muscle fiber (Fig. 4) . The metabolic implications of this finding are presently unknown. This may be somewhat analogous to the previous report of a gradient of intermyofibrillar mitochondrial content, from high to low, from the sarcolemma to the center of the muscle fiber (17) . The intermyofibrillar and subsarcolemmal mitochondrial fractions have been shown to have distinct biochemical properties and differential adaptations to increasing or decreasing muscle activity (4) .
Regression analyses (data not shown) between biochemical and TEM data also support the concept of metabolic compartmentalization. As noted earlier, the major portion of glycogen is myofibrillar. The biochemically determined total glycogen had a strong correlation with the myofibrillar value (r 2 ϭ 0.60). Proglycogen (400,000 Da), determined biochemically, had a stronger correlation with the subsarcolemmal glycogen (r 2 ϭ0.61) than with the myofibrillar one (r 2 ϭ0.48). In contrast, macroglycogen (400,000 to 10 7 Da) correlated better with the myofibrillar (r 2 ϭ 0.55) than with the subsarcolemmal (r 2 ϭ 0.34) glycogen fraction. This is consistent with our finding that single-particle size in the subsarcolemmal space was significantly smaller than that in the myofibrillar space. Further studies are required to evaluate these suggestions.
Single-Particle Distribution
The present study demonstrates for the first time that, in resting human skeletal muscle, glycogen particles present as a continuum of sizes ranging from 10 to 44 m in diameter (Fig. 5 ). This is in contrast to our hypothesis, which was based on the description of Friden et al. (10) , of two distinct populations of glycogen particles with average diameters of 22 and 56 m. However, Friden et al.'s results are based on the analysis of 144 glycogen particles, whereas we measured Ͼ55,000 granules. The mean single glycogen particle diameter was found to be 25 m, which was in agreement with values previously reported (9, 12, (25) (26) (27) 31) . Not only did we not find evidence for a bimodal distribution, we did not observe any particles larger than 44 nm. The frequency distribution of the singleparticle diameters from 11 subjects suggests that the distribution is normal, although slightly skewed on the left. The latter finding is to be expected, considering the error introduced by the 70-m sections relative to the 25-m average diameter of the glycogen particles. If Ͼ50% of a spherical granule is not included in the section, then the true diameter will be underestimated. Conversely, if Ͼ50% of such a particle is included, the correct diameter will be observed. This bias can only lead to an underestimation of a particle diameter, hence the distribution being skewed on the left. As reported by Williams (34) , this only becomes a significant problem when the object being measured has a diameter greater than the thickness of the thin section.
We found that the maximal granule diameter was 44 m. The extent to which this finding agrees with the values predicted from mathematical modeling is striking. Considerable evidence converges to propose that an optimally efficient glycogen ␤-particle would have a maximal diameter of 42 m (11, 19, 20) . According to the models, the "mature" glycogen ␤-particle (macroglycogen) would be a spherical particle arranged in 12 concentric layers (tiers) of carbohydrate, with a molecular mass of 10 7 Da. Each tier is estimated to add 3.8 m to the diameter (11) , and the amount of glucose avail-able in any outer tier is always 34.6% of the total amount of glucose in the particle (20) . This means that what appear to be small differences in granule size, especially in the larger granules, could be quantitatively very important with regard to carbohydrate storage.
There is controversy in the literature as to whether proglycogen and macroglycogen only exist as discrete entities (2) or as a wide range of molecular weights (30) . Our data firmly support the theory that there is a continuous spectrum of glycogen particles sizes, ranging from sizes considerably smaller than the upper limit of proglycogen (ϳ30 m) to sizes corresponding to the maximal macroglycogen diameter (ϳ42 m).
Fiber Types
Although fiber-type comparisons were not a main goal of the study, a preliminary examination was conducted. It has been demonstrated that mammalian Z lines vary in thickness with muscle fiber type (10, 18, 22, 27, 29) . Although the values reported vary slightly between studies, it is clear that, in any particular muscle, the widest Z lines are found in the type I fibers and the narrowest in the type IIB fibers [reviewed by Landon (18) ]. Eisenberg (6) concluded that in any one preparation, the upper and lower limits of the measured range of Z-line values may be expected to correspond to type I and type IIB fibers, respectively, but that other independent criteria are required to identify fibers containing Z lines of intermediate widths. On the basis of this, we used Z-line width as our primary criterion, and in cases where there was uncertainty, three independent investigators determined the fiber type based on the following criteria from Landon (18): 1) lipid content, 2) shape and content of the mitochondria, and 3) SR and T-tubules appearance. With the use of this technique, mean Ϯ SE of Z-line width for type I, IIA, and IIB were 92.8 Ϯ 2.8, 79.8 Ϯ 1.2, and 70.0 Ϯ 0.6 nm, respectively. These values are in agreement with those reported previously (10, 18, 22, 27) and suggest that indeed the classifications were correct. However, given the limited number of fibers that were processed, our findings regarding fiber-type differences should be viewed as preliminary. Furthermore, very few type IIB fibers were identified, and thus we only statistically compared type I and IIA fibers. This aspect needs further investigation, which should include more accurate identification of fiber types and the inclusion of more fibers.
The mean particle volume for type I fibers was significantly less than that for type IIA fibers (7,018 Ϯ 565 vs. 8,466 Ϯ 517 nm 3 , respectively). One could speculate that because type I fibers are being constantly recruited during activities of daily living, their glycogen particles are in a more dynamic state of turnover and thus are smaller. This difference may seem modest, but the difference in diameter (24.5 Ϯ 0.9 vs 25.3 Ϯ 0.5 nm, respectively) is almost 33% of a tier of glycogen, and the addition of a tier represents a 50% increase in carbohydrate.
Subsarcolemmal-to-total myofibrillar glycogen ratio, although not significantly different between fiber types, was 21% greater in type IIA compared with type I fibers. This suggests that there may be relatively less subsarcolemmal glycogen in type I than in type IIA fibers.
Friden and co-workers (10) suggested that the only consistent difference between type I and II fibers was that more glycogen particles were located at the H zone in the type II fibers. We did not differentiate between the different intramyofibrillar locations. However, we found that type I fibers had a significantly greater proportion of myofibrillar glycogen located in the intramyofibrillar space (14.3 Ϯ 0.9 vs. 9.7 Ϯ 0.7%, respectively). This finding is in agreement with that of Schmalbruch and Kamieniecka (27) , who observed that a larger proportion of the glycogen in type I fibers was located between the actin and myosin filaments, whereas the glycogen in type IIA and IIB fibers was preferentially distributed between myofibrils. Thus we are able to substantiate these earlier descriptions with quantified results.
In conclusion, this study presents a novel method to quantify the subcellular distribution of skeletal muscle glycogen. The method was found to be valid and reliable, both within and between investigators. We found that, in resting, human, skeletal muscle, 1) the glycogen distribution is compartmentalized and heterogeneous, with the glycogen being more concentrated in the subsarcolemmal space than in the myofibrillar space, and the single-particle volume was greater in the latter; and 2) single-particle sizes range from 10 to 44 m (25.2 Ϯ 2.8 m) and follow a normal distribution. The method also has the potential to be used to study fiber-type differences. A preliminary examination suggested that there were differences in the subcellular distribution of glycogen between fiber types, the single particles being bigger in type II fibers and the proportion of intramyofibrillar glycogen being greater in type I. The results of the present study represent the first quantitative demonstration of a compartmentalized pattern of subcellular glycogen deposition in human skeletal muscles.
